Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981;10:337–41.
Walters MR, Wicker DC, Riggle PC. 1,25-dihydroxyvitamin D3 receptors identified in the rat heart. J Mol Cell Cardiol. 1986;18:67–72.
Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111:1666–7.
Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2008;295:289–96.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin–angiotensin system. J Clin Invest. 2002;110:229–38.
Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93–101.
Resnick LM, Müller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105:649–54.
Kong J, Kim GH, Wei M, Sun T, Li G, Liu SQ, et al. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. Am J Pathol. 2010;177:622–31.
Lindqvist PG, Epstein E, Olsson H. Does an active sun exposure habit lower the risk of venous trombotic events? A D-lightful hypothesis J Thrombosis Haemostasis. 2009;7:605–10.
Ameri P, Ronco D, Casu M. High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis. 2010;20:633–40.
Galiè N, Humbert M. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46:1855–6.
Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425–36.
Demir M, Uyan U, Keceoclu S, Demir C. The relationship between vitamin D deficiency and pulmonary hypertension. Prague Med Rep. 2013;114:154–61.
Bogaard HJ, Al Husseini A, Farkas L. Severe pulmonary hypertension: the role of metabolic and endocrine disorders. Pulm Circ. 2012;2:148–54.
Anderson JL, May HT, Horne BD. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963–8.
Thadhani R, Appelbaum E, Pritchett Y. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307:674–84.
Mirdamadi A, Moshkdar P. Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension. Caspian J Intern Med. 2016;7:253–9.
Rios Fernández R, Fernández Roldán C, Callejas R, Ortego CN. Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain. J Rheumatol. 2010;37:1355.
De Man F, Ly Tu M, Handoko L. Dysregulated renin–angiotensin–aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:780–9.
Agnieszka C, Doan V, Sl V-R. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1269–75.
O'Connell T, Simpson R. Immunochemical identification of the 1,25-dihydroxyvitamin d3 receptor protein in human heart. Cell Biol Int. 1996;20:621–4.
Chen S, Glenn D, Ni W. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension. 2008;52:1106–12.
McGoon M, Benza L, Escribano-Subias P. Pulmonary arterial hypertension. Epidemiology and registries. J Am Coll Cardiol. 2013;62:D51–9.
William T, Abraham KF, Adams GC. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications an analysis from the acute decompensated heart failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57–64.
Thierer J, Belziti C, Francesia A. [Manejo ambulatorio de la insuficiencia cardíaca crónica en la Argentina: Estudio OFFICE IC]. Rev. Argent Cardiol. 2006;74:109–16.
Wei-Long J, Hai-Bo G, Zhang Y. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2016;39:56–61.
Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008;57:183–91.
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profile in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754–9.
Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K. 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine. 1992;4:506–12.